MGRX
MANGOCEUTICALS, INC.
Key Financials
Net Income
$-20642994
↓ 137.1%
Gross Profit
$250386
↓ 34.1%
Revenue
$456021
↓ 26.0%
Operating Income
$-18032349
↓ 126.2%
EPS (Diluted)
$-2.17
↑ 55.2%
Total Assets
$16.1M
↑ 4.7%
Shareholders' Equity
$15.2M
↑ 9.0%
Total Liabilities
$890568.00
↓ 37.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/13/2026 | View on SEC |
| 425 | 8/13/2026 | View on SEC |
| 425 | 8/6/2026 | View on SEC |
| 425 | 8/4/2026 | View on SEC |
| 8-K | 8/4/2026 | View on SEC |
| 425 | 7/30/2026 | View on SEC |
| 425 | 7/30/2026 | View on SEC |
| 8-K | 7/30/2026 | View on SEC |
| S-8 | 7/10/2026 | View on SEC |
| 8-K | 7/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MGRX |
| Company Name | MANGOCEUTICALS, INC. |
| CIK | 1938046 |
| Sector | Services-Misc Health & Allied Services, NEC |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 8090 |
| SIC Description | Services-Misc Health & Allied Services, NEC |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | TX |
| Phone | (833) 626-4679 |